Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Mitomycin × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 5 Appendiceal Neoplasms 3 Anus Neoplasms 3 Pseudomyxoma Peritonei 2 Peritoneal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Sarcoma 1 Rectal Neoplasms 1 Pleural Neoplasms 1 Ovarian Neoplasms 1 Necrosis 1 Mediastinal Neoplasms 1 HIV Infections 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Anal Canal Carcinoma 1

Interventions

Dexamethasone 12 Cyclophosphamide 12 pembrolizumab 11 Rituximab 11 venetoclax 9 fludarabine 9 pomalidomide 8 Lenalidomide 7 Gemcitabine 6 Cytarabine 6 Calcium Dobesilate 6 glofitamab 5 Temozolomide 5 Nivolumab 5 Etoposide 5 Bevacizumab 5 selinexor 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 carfilzomib 4 Doxorubicin 4 Capecitabine 4 Azacitidine 4 zanubrutinib 3 tisagenlecleucel 3 elotuzumab 3 belantamab mafodotin 3 atezolizumab 3 Vincristine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡